Dementia: An update to refresh your memory

Internal Medicine Journal

Volumn 32, Issue 11, 2002, Pages 535-540

  Logiudice, D ^a  

^a NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

Author keywords

Behavioural and psychological symptoms of dementia; Cholinesterase inhibitors; Dementia; Mild cognitive impairment

Indexed keywords

BEHAVIOR DISORDER; COGNITIVE DEFECT; COMMUNITY; COUNSELING; DEMENTIA; FAMILY; HEALTH CARE MANAGEMENT; HEALTH EDUCATION; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW; SYMPTOM;

ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION; DEMENTIA; DEMENTIA, VASCULAR; HUMANS; MEMORY; NEUROPSYCHOLOGICAL TESTS;

EID: 0036401452     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00294.x     Document Type: Review

References (29)

1. Jorm AF, Henderson AS. Dementia in Australia. Canberra: Australian Government Publishing Service; 1998. Aged and Community Care Service Development and Evaluation Report No. 35.
2. Department of Health Housing and Community services. Mid-term Review of the Aged Care Reform Strategy: Putting the Pieces Together. A National Action Plan for Dementia Care. Canberra: Commonwealth of Australia; 1992.
3. Eastley R, Wilcock G. Assessment and differential diagnosis of dementia. In: O'brien J, Ames D, Burns A. Dementia, 2nd edn. London: Arnold; 2000.
4. Wolfson C, Wolfson DB, Asgharian M, M'Lan CE, Ostby T, Hogan DB et al. A re-evaluation of the duration of survival after onset of dementia. N Engl J Med 2001; 344: 1111-16.
5. Brodaty H, Gresham M, Luscombe G. The Prince Henry Hospital Dementia Caregivers' Training Programme. Int J Geriatr Psychiatry 1997; 12: 183-92.
6. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Cummings JL et al. Practice parameter: management of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1154-66.
7. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997; 337: 1667-74.
8. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Stevens JC et al. Practice parameter: diagnosis of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143-53.
9. Celsis P. Age related cognitive decline, mild cognitive impairment or pre clinical Alzheimer's Disease. Ann Med 2000; 32: 6-14.
10. Jorm AF, Christensen H, Korten AE, Jacomb PA, Henderson AS. Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7-8 years. Psychol Med 2001; 31: 441-9.
11. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population based validation study. Neurology 2001; 56: 37-42.
12. Skoog I. Detection of preclinical Alzheimer's Disease. N Engl J Med 2000; 373: 502-3.
13. Snowdon DA, Greiner LH, Martimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer Disease. The Nun Study. JAMA 1997; 277: 813-17.
14. Ince PG. Pathological correlates of late onset dementia in a multicentre, community based population in England and Wales. Lancet 2001; 357: 169-75.
15. Creasey H, Waite LM, Grayson DA, Bennett HP, Dent O, Broe GA. The impact of neurodegenerative disorders on ageing: an overview of the Sydney Older Persons Study. Australasian J Ageing 2001; 20: 10-15.
16. O'Brien JT, Desmond P, Ames D, Schweitzer I, Tress B. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychol Med 1997; 27: 1267-75.
17. Jorm AF. Is depression a risk factor for dementia or cognitive decline? A Rev Gerontol 2000; 46: 219-27.
18. Lidell MB, Lovestone S, Owen M. Genetic risk of Alzheimer's disease: advising relatives. Br J Psychiatry 2001; 178: 7-11.
19. Masters C, Beyreuther K. Alzheimer's disease. Br Med J 1998; 316: 446-8.
20. Brodaty H, Ames D, Boundy KL, Hecker J, Snowdon J, Yates M et al. Pharmacological treatment of cognitive deficits in Alzheimer's Disease. Med J Aust 2001; 175: 324-9.
21. Hachinski V, Munoz D. Vascular factors in cognitive impairment - where are we now? Ann New York Acad Sciences 2000; 903: 1-5.
22. Sachdev P, Brodaty H, Looi J. Vascular dementia: Diagnosis, management and possible prevention. Med J Aust 1999; 170: 81-5.
23. McKeith I, O'Brien J. Dementia with Lewy bodies. Aust N Z J Psychiatry 1999; 33: 800-9.
24. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Cicin-Sain A et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double blind, placebo controlled international study. Lancet 2000; 356: 2031-6.
25. Neary D, Snowden J, Gustafson L, Passant U, Stuss D, Benson DF et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
26. Flicker L, LoGiudice D, Carlin JB, Ames D. The predictive value of dementia screening instruments in clinical populations. Int J Geriatr Psychiatry 1997; 12: 203-9.
27. Opie J, Rosewarne R, O'Connor D. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Aust N Z J Psychiatry 1999; 33: 789-99.
28. Thompson C, Spilsbury K. Support For Carers of People With Alzheimer's Type Dementia (Cochrane Review). The Cochrane Library, Issue 3. Oxford: Update Software; 2001.
29. American Psychiatric Association. Diagnosis and Statistical Manual of Mental Disorders, 4th edn. Washington: American Psychiatric Association; 1994.